Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
Header
News archive
News Archive Navigation
icon
News Archive Navigation Language
Language Preferences
Showing 1045 results
September 2016
-
Media ReleaseNovartis presents new positive data at EHMTIC showing AMG 334 significantly reduces monthly migraine days in chronic migraineDetailed results from Phase II study in chronic migraine prevention showed patients on AMG 334 (erenumab) were significantly more likely to experience a 50% or more reduction in monthly migraine…
-
Media ReleaseNovartis Foundation showcases progress in leprosy elimination programs at 19th International Leprosy CongressEmerging evidence from first 18 months of LPEP program demonstrates operational feasibility integrating single-dose rifampicin into routine control programs in 6 countries Retrospective…
-
Media ReleaseNew Novartis point of care Niji(TM) System may provide earlier diagnosis of severe allergic asthma and faster treatment decisionsNijiTM System, Total IgE Test delivers results rapidly, allowing for quick in-office diagnosis of IgE-mediated allergic disorders and faster treatment decisions Point of care in office…
-
Media ReleaseAlcon launches the NGENUITY® 3D Visualization System designed to further enhance retinal surgeon experienceHeads-up design using high definition 3D screen engineered to improve surgeons posture and may reduce fatigue[1] Offers enhanced 3D visualization with high-definition resolution, image…
-
Media ReleaseNovartis' Ultibro® Breezhaler® consistently more effective than Seretide®* in reducing COPD flare-ups across different patient groupsUltibro® Breezhaler® reduced rate of all COPD exacerbations across different patient sub-groups vs Seretide® in new analyses from FLAME study Analyses show that Ultibro Breezhaler lowered…
August 2016
-
Media ReleaseAirFluSal® Forspiro® showed superiority at 12 months over Seretide® Diskus®[1] in persistence to treatmentNew study shows that rate of patient persistence using Sandoz AirFluSal Forspiro is twice as high as for reference product Seretide® Diskus®. Study highlights importance of improving…
-
Media ReleaseFDA approves Sandoz Erelzi(TM) to treat multiple inflammatory diseasesErelzi is the first biosimilar etanercept approved by the FDA, offering expanded access to this important medicine Erelzi is approved for all indications included in the reference product's…
-
Media ReleaseNovartis convenes experts to discuss new technologies in healthcare at Novartis International BioCamp13th International Biotechnology Leadership Camp focuses on potential of new technologies to fundamentally transform biomedical research and the pharmaceutical business Interactive program…
-
Media ReleaseNovartis announces positive phase III results showing efficacy of BAF312 in patients with secondary progressive MSThe Phase III EXPAND study of BAF312 (siponimod) in secondary progressive multiple sclerosis (SPMS) met its primary endpoint of reducing the risk of three-month confirmed disability progression…
-
Media ReleaseSix leading scientists to receive prestigious Novartis Prizes for Immunology at 16th International Congress of ImmunologyThe Basic Immunology Prize is awarded to John Kappler, Philippa Marrack and Harald von Boehmer for demonstrating that the ability of the immune system to discriminate "self" from "non-self" is…
-
Media ReleaseNovartis CDK4/6 inhibitor LEE011 (ribociclib) receives FDA Breakthrough Therapy designation as first-line treatment for HR+/HER2- advanced breast cancerDesignation underscores the continuing unmet need of the HR+/HER2- advanced breast cancer population and the potential of LEE011 (ribociclib) as an effective new treatment option Results…
-
Media ReleaseAlcon achieves US approval for CyPass® Micro-Stent, a micro invasive surgical device to treat glaucomaUS Food and Drug Administration (FDA) grants approval for CyPass Micro-Stent for sale in the US, expanding Alcon's surgical presence to treat glaucoma The CyPass Micro-Stent is designed to…
Pagination
- ‹ Previous page
- 1
- …
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- …
- 88
- › Next page